Cardiac autonomic neuropathy

Cardiac Autonomic Testing And Diagnosing Heart Disease. “A Clinical Perspective” 1 Of 2

Abstract Background Coronary heart disease (CHD) is a major health concern, affecting nearly half the middle-age population and responsible for nearly one-third of all deaths. Clinicians have responsibilities beyond diagnosing CHD, including risk stratification of patients for major adverse cardiac events (MACE), modifying the risks and treating the patient. In this first of a two-part […]

Cardiac Autonomic Testing And Diagnosing Heart Disease. “A Clinical Perspective” 1 Of 2 Read More »

Differential Effects of Adrenergic Antagonists (Carvedilol vs. Metoprolol) on Parasympathetic and Sympathetic Activity: A Comparison of Measures 1 of 2

BACKGROUND  Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk. Specific and sensitive measures of CAN are needed for early identification and treatment to avoid complications, preferably in the preclinical state.  OBJECTIVES  In this first of two articles, the patient cohort is described and two measures of autonomic function are reviewed: the traditional

Differential Effects of Adrenergic Antagonists (Carvedilol vs. Metoprolol) on Parasympathetic and Sympathetic Activity: A Comparison of Measures 1 of 2 Read More »

Scroll to Top

Become An Authorized Distributor